3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Status
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
3
Sponsor
Cancer Type
Sarcoma
3
Conditions
Osteosarcoma
3
Neoplasms, Bone Tissue
1
Interventions
Ifosfamide
15
Methotrexate
12
Doxorubicin
12
Filgrastim
10
Cisplatin
10
Cyclophosphamide
9
Etoposide
8
Gemcitabine
7
cabozantinib
6
apatinib
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
X-Rays
5
Specimen Handling
5
Sirolimus
5
Phantoms, Imaging
5
Nivolumab
5
Neoadjuvant Therapy
5
camrelizumab
4
Vincristine
4
Topotecan
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Drug Therapy
4
Docetaxel
4
Biopsy
4
regorafenib
3
palbociclib
3
olaparib
3
mifamurtide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2
×
Osteosarcoma
×
mifamurtide
×
Clear all
NCT03643133
2026-05-19
SARCOME13
UNICANCER
Phase 2
Active not recruiting
60 enrolled
NCT01459484
2024-05-20
ISG/OS-2
Italian Sarcoma Group
Phase 2
Completed
225 enrolled
NCT02441309
2019-09-13
MEMOS
University of Oxford
Phase 2
Terminated
8 enrolled
17 charts